Par Health USA, LLC recalls
2 recalls filed under Par Health USA, LLC. The most recent was published October 7, 2026.
-
Class II · 18 days ago
Par Health USA, LLC Buprenorphine Hydrochloride, Injection 0.3 mg/mL recall: Crystallization
Crystallization
-
Class II · 4 months ago
Par Health USA, LLC Buprenorphine HCl, CIII, Injection, 0.3 mg/mL recall: Crystallization; identified as Buprenorphine free base
Crystallization; identified as Buprenorphine free base
About this page
Par Health USA, LLC appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.